Wells Fargo’s Ocugen OCGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $141K | Buy |
77,901
+73,900
| +1,847% | +$128K | ﹤0.01% | 4913 |
|
|
2025
Q4 | $5.4K | Buy |
4,001
+2,931
| +274% | +$4.17K | ﹤0.01% | 6081 |
|
|
2025
Q3 | $1.74K | Sell |
1,070
-10,427
| -91% | -$11.6K | ﹤0.01% | 6201 |
|
|
2025
Q2 | $11.2K | Sell |
11,497
-135,760
| -92% | -$113K | ﹤0.01% | 5924 |
|
|
2025
Q1 | $104K | Buy |
147,257
+5,484
| +4% | +$3.79K | ﹤0.01% | 5081 |
|
|
2024
Q4 | $114K | Buy |
141,773
+54,935
| +63% | +$50.3K | ﹤0.01% | 5125 |
|
|
2024
Q3 | $86.2K | Sell |
86,838
-3,213
| -4% | -$4.41K | ﹤0.01% | 5102 |
|
|
2024
Q2 | $140K | Buy |
90,051
+83,016
| +1,180% | +$129K | ﹤0.01% | 4743 |
|
|
2024
Q1 | $11.5K | Sell |
7,035
-3,818
| -35% | -$3.2K | ﹤0.01% | 5721 |
|
|
2023
Q4 | $6.24K | Buy |
10,853
+169
| +2% | +$68 | ﹤0.01% | 5927 |
|
|
2023
Q3 | $4.27K | Buy |
10,684
+523
| +5% | +$258 | ﹤0.01% | 5978 |
|
|
2023
Q2 | $5.52K | Sell |
10,161
-40,360
| -80% | -$25.9K | ﹤0.01% | 6061 |
|
|
2023
Q1 | $43.1K | Buy |
50,521
+42,021
| +494% | +$45.8K | ﹤0.01% | 5240 |
|
|
2022
Q4 | $11.1K | Sell |
8,500
-16,561
| -66% | -$25.8K | ﹤0.01% | 5509 |
|
|
2022
Q3 | $45K | Sell |
25,061
-3,953
| -14% | -$9.84K | ﹤0.01% | 5009 |
|
|
2022
Q2 | $66K | Sell |
29,014
-102,940
| -78% | -$246K | ﹤0.01% | 4881 |
|
|
2022
Q1 | $435K | Sell |
131,954
-55,168
| -29% | -$194K | ﹤0.01% | 4512 |
|
|
2021
Q4 | $852K | Buy |
187,122
+26,429
| +16% | +$200K | ﹤0.01% | 4244 |
|
|
2021
Q3 | $1.15M | Buy |
160,693
+145,477
| +956% | +$1.07M | ﹤0.01% | 4123 |
|
|
2021
Q2 | $123K | Buy |
15,216
+9,297
| +157% | +$78.5K | ﹤0.01% | 5219 |
|
|
2021
Q1 | $40K | Buy |
5,919
+364
| +7% | +$2.42K | ﹤0.01% | 5916 |
|
|
2020
Q4 | $10K | Buy |
5,555
+4,727
| +571% | +$2.28K | ﹤0.01% | 6024 |
|
|
2020
Q3 | $0 | Buy |
828
+612
| +283% | +$235 | ﹤0.01% | 6718 |
|
|
2020
Q2 | $0 | Buy |
216
+2
| +0.9% | +$1 | ﹤0.01% | 6653 |
|
|
2020
Q1 | $0 | Buy |
+214
| New | +$106 | ﹤0.01% | 6609 |
|
|
2019
Q2 | – | Sell |
-17
| Closed | – | – | 6539 |
|
|
2019
Q1 | $0 | Buy |
+17
| New | +$145 | ﹤0.01% | 6327 |
|
|
2017
Q3 | – | Sell |
-17
| Closed | -$2K | – | 6417 |
|
|
2017
Q2 | $2K | Hold |
17
| – | – | ﹤0.01% | 6055 |
|
|
2017
Q1 | $2K | Buy |
+17
| New | +$1.72K | ﹤0.01% | 6168 |
|
Other funds holding OCGN
VCM
RI
IC
Wells Fargo's OCGN Position: Q1 2026 in Review
Wells Fargo increased its Ocugen (OCGN) stake by 1,847% in Q1 2026, buying an estimated $128K and bringing the position to 77,901 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #4913.
Wells Fargo first reported a position in OCGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.15M in Q3 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.
- Wells Fargo held 77,901 shares of Ocugen worth $141K as of Q1 2026.
- Wells Fargo bought 73,900 Ocugen shares in Q1 2026, an estimated $128K.
- Ocugen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4913 holding.
- Wells Fargo first reported a position in Ocugen in Q1 2017 and has held it in 28 quarters since.
- Wells Fargo's Ocugen position peaked at $1.15M in Q3 2021.
- 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.